Decibel Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Decibel Therapeutics generated cash of -$56,898,000, which is less than the previous year. Cash used in financing activities reached the amount of -$213,000 last year. Net change in cash is therefore -$2,014,000.
Cash Flow
| 2018 | -36.08M | -71.38M | 55.06M |
|---|---|---|---|
| 2019 | -49.41M | 57.33M | -5K |
| 2020 | -32.66M | -13.01M | 54.85M |
| 2021 | -43.15M | -100.99M | 152.51M |
| 2022 | -56.89M | 55.09M | -213K |
DBTX Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 37.58M | 29.21M | 20.03M | 12.12M | 64.52M |
Operating activities | |||||
Net income | -63.00M | -51.82M | -39.33M | -42.67M | -36.16M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.46M | 1.41M | 1.64M | 1.76M | 1.47M |
Stock-based compensation expense | 3.2M | 2.81M | 2.81M | 952K | 455K |
| Deferred income tax benefit | 3.2M | 2.81M | 2.81M | 952K | 455K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 11.40M | -10.16M | -1.23M | 0 | 0 |
Inventories | 0 | 2.97M | -1.08M | 0 | 0 |
Accounts payable | -3.12M | 1.88M | 1.12M | -56K | 605K |
Cash generated by operating activities | -56.89M | -43.15M | -32.66M | -49.41M | -36.08M |
Investing activities | |||||
Purchases Of Investments | -97.51M | -197.45M | -26.58M | -31.66M | -117.90M |
Investments In Property Plant And Equipment | -463K | -745K | -273K | -717K | -1.28M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 55.09M | -100.99M | -13.01M | 57.33M | -71.38M |
Financing activities | |||||
Common Stock Issued | 0 | 128.24M | 54.8M | -5K | 56K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -1K | -15K | -5K | 0 |
Repayments of term debt | 0 | -193K | -75K | 0 | 0 |
Cash used in financing activities | -213K | 152.51M | 54.85M | -5K | 55.06M |
Net Change In Cash | -2.01M | 8.36M | 9.17M | 7.91M | -52.40M |
Cash at end of period | 35.56M | 37.58M | 29.21M | 20.03M | 12.12M |
| Data source | Data source | Data source |